Liminatus Pharma Inc. (LIMN) vs NuCana PLC Sponsored ADR (NCNA)
Liminatus Pharma Inc. and NuCana PLC Sponsored ADR are both Biotechnology companies. Liminatus Pharma Inc. and NuCana PLC Sponsored ADR are of similar size ($5.7M and $5.6M). Across the 10 metrics below, Liminatus Pharma Inc. leads on 5 and NuCana PLC Sponsored ADR on 5.
Valuation
Profitability
| Metric | LIMN | NCNA | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 294.43% | (68.70%) | (57.72%) |
| Return on assets | (471.47%) | (45.24%) | (49.22%) |
| Return on invested capital | 0.00% | (1,130.23%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack